Evidence map›Paper›PMID 31576060›Full record

ArticleNature cell biology2019

The NSL complex maintains nuclear architecture stability via lamin A/C acetylation.

Adam Karoutas, Witold Szymanski, Tobias Rausch, Sukanya Guhathakurta, Eva A Rog-Zielinska, Remi Peyronnet, Janine Seyfferth, Hui-Ru Chen, Rebecca de Leeuw, Benjamin Herquel and 6 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Microtubule Minus-End Binding Proteins in Cancer: Advances.Diagnostics (Basel, Switzerland) · 2025
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Adam KaroutasDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0003-4264-8203
Witold SzymanskiProteomics Facility, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-1202-3299
Tobias RauschEuropean Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-5773-5620
Sukanya GuhathakurtaDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Eva A Rog-ZielinskaInstitute for Experimental Cardiovascular Medicine, University Heart Center Freiburg & Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
Remi PeyronnetInstitute for Experimental Cardiovascular Medicine, University Heart Center Freiburg & Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
Janine SeyfferthDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Hui-Ru ChenDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Rebecca de LeeuwDepartment of Biochemistry, University of Zurich, Zurich, Switzerland.
Benjamin HerquelDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Hiroshi KimuraCell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0854-083X
Gerhard MittlerProteomics Facility, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Peter KohlInstitute for Experimental Cardiovascular Medicine, University Heart Center Freiburg & Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
Ohad MedaliaDepartment of Biochemistry, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-0994-2937
Jan O KorbelEuropean Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-2798-3794
Asifa AkhtarDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. akhtar@ie-freiburg.mpg.de.ORCID http://orcid.org/0000-0001-8973-6193
University of Freiburg · DEMax Planck Institute of Immunobiology and Epigenetics · DEEuropean Molecular Biology Laboratory · DEBen-Gurion University of the Negev · ILTokyo Institute of Technology · JPUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While nuclear lamina abnormalities are hallmarks of human diseases, their interplay with epigenetic regulators and precise epigenetic landscape remain poorly understood. Here, we show that loss of the lysine acetyltransferase MOF or its associated NSL-complex members KANSL2 or KANSL3 leads to a stochastic accumulation of nuclear abnormalities with genomic instability patterns including chromothripsis. SILAC-based MOF and KANSL2 acetylomes identified lamin A/C as an acetylation target of MOF. HDAC inhibition or acetylation-mimicking lamin A derivatives rescue nuclear abnormalities observed in MOF-deficient cells. Mechanistically, loss of lamin A/C acetylation resulted in its increased solubility, defective phosphorylation dynamics and impaired nuclear mechanostability. We found that nuclear abnormalities include EZH2-dependent histone H3 Lys 27 trimethylation and loss of nascent transcription. We term this altered epigenetic landscape "heterochromatin enrichment in nuclear abnormalities" (HENA). Collectively, the NSL-complex-dependent lamin A/C acetylation provides a mechanism that maintains nuclear architecture and genome integrity.

Indexed as

AcetylationAnimalsCell NucleusCells, CulturedEpigenesis, GeneticFibroblastsHeterochromatinHistone AcetyltransferasesHistonesLamin Type AMiceMice, Inbred C57BLMice, KnockoutNuclear ProteinsHeterochromatinHistone AcetyltransferasesHistonesKANSL1 protein, mouseKat8 protein, mouseLamin Type ANuclear Proteins

Identifiers

PMID31576060
OpenAlexW2977830322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.